Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

OBJECTIVES: Whether the duration of maintenance treatment with azathioprine (AZA) affects the outcome of ulcerative colitis (UC) is unclear. We investigated clinical outcomes and any predictive factors after withdrawal of AZA in UC. METHODS: In this multicenter observational retrospective study, 12...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Cassinotti, A, Actis, G, Duca, P, Massari, A, Colombo, E, Gai, E, Annese, V, D'Albasio, G, Manes, G, Travis, S, Porro, G, Ardizzone, S
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registos relacionados

Azathioprine in ulcerative colitis.
Por: Jewell, D, et al.
Publicado em: (1972)

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
Por: Cassinotti, A, et al.
Publicado em: (2009)

Azathioprine-Induced Pericarditis in a Patient with Ulcerative Colitis
Por: C David Simpson
Publicado em: (1997-01-01)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
Por: Kyrillus S Shohdy, et al.
Publicado em: (2018-01-01)

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.
Por: Jewell, D, et al.
Publicado em: (1974)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
Por: Jewell, D, et al.
Publicado em: (1972)

Review: Immunomodulators for all patients with inflammatory bowel disease?
Por: Sandro Ardizzone, et al.
Publicado em: (2010-01-01)

Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
Por: Maryam Rezaiee, et al.
Publicado em: (2019-05-01)

Modified Kudo classification can improve accuracy of virtual chromoendoscopy with FICE in endoscopic surveillance of ulcerative colitis
Por: Andrea Cassinotti, et al.
Publicado em: (2020-09-01)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
Por: Marianne Kiszka-Kanowitz, et al.
Publicado em: (2022-03-01)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
Por: Tong Li, et al.
Publicado em: (2020-11-01)

6-Mercaptopurine Or Azathioprine?
Por: McGovern, D, et al.
Publicado em: (2007)

Biologics for Ulcerative Colitis: Status of the Art and General Considerations
Por: Giovanni Clemente Actis
Publicado em: (2017-03-01)

Infliximab and azathioprine: bridge or parachute?
Por: Travis, S
Publicado em: (2006)

Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
Por: Gianni Imperiali, et al.
Publicado em: (2017-01-01)

A rare case report: Myopathy related to the interaction between azathioprine and infliximab in the treatment of ulcerative colitis and ankylosing spondylitis
Por: Lingyu Fu, et al.
Publicado em: (2024-06-01)

Adalimumab for the treatment of Crohn&rsquo;s disease
Por: Andrea Cassinotti, et al.
Publicado em: (2008-09-01)

Intensification of maintenance therapy with infliximab in ulcerative colitis
Por: Francesc Casellas

Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up
Por: Ahmet Basturk, et al.
Publicado em: (2017-09-01)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
Por: Maconi G, et al.
Publicado em: (2021-04-01)

The European consensus on ulcerative colitis: new horizons?
Por: Stange, E, et al.
Publicado em: (2008)

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.
Por: Campbell, A, et al.
Publicado em: (1976)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Por: Jairath, V, et al.
Publicado em: (2017)

Review article: maintenance therapy in patients with ulcerative colitis.
Por: Orchard, T, et al.
Publicado em: (2006)

Predicting outcome in severe ulcerative colitis.
Por: Travis, S
Publicado em: (2004)

Ulcerative colitis and sarcoidosis.
Por: Barr, G, et al.
Publicado em: (1986)

Insights into the role of gastrointestinal ultrasound in ulcerative colitis
Por: Cristina Bezzio, et al.
Publicado em: (2021-10-01)

Salicylates for ulcerative colitis--their mode of action.
Por: Travis, S, et al.
Publicado em: (1994)

Therapy of ulcerative colitis: state of the art.
Por: Brain, O, et al.
Publicado em: (2008)

Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
Por: Rubin, D, et al.
Publicado em: (2019)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
Por: An-Yu Chen, et al.
Publicado em: (2019-09-01)

Therapeutic landscape for ulcerative colitis: where is the Adacolumn&reg; system and where should it be?
Por: D&rsquo;Inc&agrave; R, et al.
Publicado em: (2013-01-01)

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
Por: I. G. Bakulin, et al.
Publicado em: (2017-11-01)

Expression of lectins in nonspecific ulcerative colitis
Por: Maslyakova G.N., et al.
Publicado em: (2012-12-01)

Comparing disease activity indices in ulcerative colitis
Por: Walsh, A, et al.
Publicado em: (2014)

Comparing disease activity indices in ulcerative colitis.
Por: Walsh, A, et al.
Publicado em: (2014)

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Por: Travis, S, et al.
Publicado em: (1994)

Azathioprine and Steroids
Por: Knight, SR, et al.
Publicado em: (2008)

Oral methotrexate in ulcerative colitis.
Por: Cummings, JR, et al.
Publicado em: (2005)

Assessing disease activity in patients with ulcerative colitis.
Por: Walsh, A, et al.
Publicado em: (2012)